CVS Health (CVS) Tops Q4 EPS by 19c, Beats on Revenue; Offers FY25 EPS Guidance

CVS Health (NYSE: CVS) reported Q4 EPS of $1.19, $0.19 better than the analyst estimate of $1.00. Revenue for the quarter came in at $97.7 billion versus the consensus estimate of $96.97 billion.

GUIDANCE:

CVS Health sees FY2025 EPS of $5.75-$6.00, versus the consensus of $5.97.

For earnings history and earnings-related data on CVS Health (CVS) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Cerebras Systems (CBRS) call put ratio 1 call to 1.1 puts into quarter results
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits